| 2024 |
Lung Disease Management by Iloprost-Loaded Nanoparticles to Address Hyperinflammation Associated with Cystic Fibrosis |
Articolo in rivista |
Go to |
| 2024 |
Rapamycin-based inhaled therapy for potential treatment of COPD-related inflammation: production and characterization of aerosolizable nano into micro (NiM) particles |
Articolo in rivista |
Go to |
| 2024 |
Lipid–Polymer Hybrid Nanoparticles in Microparticle-Based Powder: Evaluating the Potential of Methylprednisolone Delivery for Future Lung Disease Treatment via Inhalation |
Articolo in rivista |
Go to |
| 2024 |
Exploiting inhalable microparticles incorporating hybrid polymer-lipid nanoparticles loaded with Iloprost manages lung hyper-inflammation |
Articolo in rivista |
Go to |
| 2024 |
Nanostructured Hybrid Polymer‐Lipid Drug Delivery Platforms for Rapamycin Repositioning in Anticancer Therapy |
Articolo in rivista |
Go to |
| 2023 |
TAT decorated siRNA polyplexes for inhalation delivery in anti-asthma therapy |
Articolo in rivista |
Go to |
| 2022 |
Inhalable Formulation Based on Lipid-Polymer Hybrid Nanoparticles for the Macrophage Targeted Delivery of Roflumilast |
Articolo in rivista |
Go to |
| 2022 |
Inhalable polymeric microparticles as pharmaceutical porous powder for drug administration |
Articolo in rivista |
Go to |
| 2021 |
Rapamycin-loaded polymeric nanoparticles as an advanced formulation for macrophage targeting in atherosclerosis |
Articolo in rivista |
Go to |
